XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Accounts and Notes Receivable (Tables)
 9 Months Ended
Sep. 30, 2024
Accounts and Notes Receivable [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
(In millions)September 30, 2024December 31, 2023September 30, 2023
Accounts receivable – trade1
$4,260 $4,210 $4,013 
Notes receivable – trade1,2
1,241 119 1,307 
Other3
1,150 1,159 1,261 
Total accounts and notes receivable - net$6,651 $5,488 $6,581 
1.Accounts and notes receivable – trade are net of allowances of $188 million, $205 million and $201 million at September 30, 2024, December 31, 2023 and September 30, 2023, respectively.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2024, December 31, 2023 and September 30, 2023, there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, royalties, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total current assets. In addition, Other includes amounts due from nonconsolidated affiliates of $145 million, $131 million and $137 million as of September 30, 2024, December 31, 2023 and September 30, 2023, respectively.
Accounts Receivable, Allowance for Credit Loss [Table Text Block]
(In millions)
2023
Balance at December 31, 2022$194 
Net provision for credit losses
10 
Other - net of write-offs charged against allowance
(3)
Balance at September 30, 2023
$201 
2024
Balance at December 31, 2023$205 
Net provision for credit losses31 
Other - net of write-offs charged against allowance
(48)
Balance at September 30, 2024
$188